Error: Could not add to watchlist. X

CASI Pharmaceuticals Inc

+ Watchlist
ENMD:US
Ticker Change
ENMD:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
CASI Pharmaceuticals Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.
ADDRESS
9620 Medical Center Drive
Suite 300
Rockville, MD 20850
United States
PHONE
1-240-864-2600
  • Ren Ken K
    Chief Executive Officer
  • Rong Chen
    Chief Medical Officer
  • Cynthia Wong Hu
    COO/VP/Secretary/General Counsel
  • Sara B Capitelli
    VP:Finance/Principal Acctg Ofcr
Show More